New Haven-based healthcare solutions company, Precipio, Inc., is at the forefront of diagnostic products, reagents, and services in the United States. With a focus on diagnostic blood cancer testing services, the company boasts an impressive range of offerings, including IV-Cell, a groundbreaking proprietary cell culture media that allows for the simultaneous culturing of four hematopoietic cell lineages, as well as HemeScreen, a suite of robust genetic diagnostic panels, and COVID-19 antibody tests. Additionally, Precipio, Inc. supplies its cutting-edge ICE- technology kits to bio-pharma customers, ensuring widespread access to its innovative products.